SecurityHHS / Harte-Hanks, Inc. (416196103)
President and CEOPUCKETT KAREN A
IndustryDirect Mail Advertising Services
Institutional Owners30
Institutional Shares4,440,521 - 70.97%
Common Shares Outstanding6,256,504 shares (as of 2018-03-31)
Institutional Value$ 22,844,000 USD

Institutional Stock Ownership and Shareholders()

HHS / Harte-Hanks, Inc. Institutional Ownership

Harte-Hanks, Inc. (NYSE:HHS) has 30 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 4,440,521 shares. Largest shareholders include BlackRock Institutional Trust Company, N.A., Fondren Management LP, Dimensional Fund Advisors Lp, BlackRock Advisors LLC, VIEX Capital Advisors, LLC, Eidelman Virant Capital, Renaissance Technologies LLC, BlackRock Inc., Credit Suisse Ag/, and BlackRock Fund Advisors.
Harte-Hanks, Inc. (NYSE:HHS) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

Embed this chart! (it updates automatically)
<a href="https://fintel.io/so/us/hhs"><img src="https://images.fintel.io/us-hhs-so.png" alt="HHS / Harte-Hanks, Inc. Institutional Ownership"><a>

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2018-05-15 13F-HR TWO SIGMA ADVISERS, LP 51,629 0 -100.00 49 0 -100.00
2018-05-14 13F-HR Royce & Associates LLC 284,200 0 -100.00 270 0 -100.00
2017-02-10 13F-HR BlackRock Fund Advisors 2,334,541 128,930 -94.48 3,782 195 -94.84
2017-02-10 13F-HR BlackRock Investment Management, LLC 28,195 8,461 -69.99 46 13 -71.74
2016-11-14 13F-HR MASON STREET ADVISORS, LLC 9,577 16
2018-05-15 13F-HR Bank of New York Mellon Corp 41,716 0 -100.00 40 0 -100.00
2018-05-15 13F-HR Invesco Ltd. 145,221 0 -100.00 138 0 -100.00
2018-05-14 13F-HR BOOTHBAY FUND MANAGEMENT, LLC 0 32,669 0 299
2018-05-15 13F-HR JACOBS LEVY EQUITY MANAGEMENT, INC 12,600 0 -100.00 12 0 -100.00
2018-05-15 13F-HR GOLDMAN SACHS GROUP INC 14,086 0 -100.00 13 0 -100.00
2016-11-14 13F-HR Central Square Management LLC 17,362 15,843 -8.75 28 26 -7.14
2018-05-15 13F-HR VANGUARD GROUP INC 1,210,390 120,411 -90.05 1,148 1,110 -3.31
2018-05-15 13F-HR RBF Capital, LLC 32,289 0 -100.00 31 0 -100.00
2018-04-19 13F-HR Eidelman Virant Capital 2,102,823 208,782 -90.07 1,994 1,911 -4.16
2018-05-09 13F-HR NORTHERN TRUST CORP 14,123 130
2017-02-10 13F-HR BlackRock Advisors LLC 324,775 294,039 -9.46 526 444 -15.59
2018-05-15 13F-HR VIEX Capital Advisors, LLC 2,734,848 274,805 -89.95 2,595 2,516 -3.04
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,672,539 1,741,817 4.14 2,710 2,630 -2.95
2018-05-14 13F-HR MORGAN STANLEY 179,128 17,106 -90.45 170 157 -7.65
2018-05-02 13F-HR WELLS FARGO & COMPANY/MN 73 7 -90.41 0 0
2017-02-10 13F-HR BlackRock Group LTD 154,228 121,739 -21.07 250 184 -26.40
2018-05-15 13F-HR MILLENNIUM MANAGEMENT LLC 91,738 0 -100.00 87 0 -100.00
2018-05-18 13F-HR/A ROYAL BANK OF CANADA 21,881 2,185 -90.01 21 20 -4.76
2018-05-15 13F-HR Fondren Management LP 2,933,243 464,800 -84.15 2,783 4,256 52.93
2017-08-18 13F-HR WFG Advisors, LP 4,000 14,000 250.00 6 14 133.33
2018-05-14 13F-HR RAYMOND JAMES & ASSOCIATES 20,000 0 -100.00 19 0 -100.00
2018-05-15 13F-HR CREDIT SUISSE AG/ 1,317,000 131,710 -90.00 1,250 1,206 -3.52
2018-05-15 13F-HR DEUTSCHE BANK AG\ 3,447 0 -100.00 3 0 -100.00
2018-05-11 13F-HR DIMENSIONAL FUND ADVISORS LP 3,394,875 330,531 -90.26 3,221 3,047 -5.40
2018-05-09 13F-HR GABELLI FUNDS LLC 13,000 0 -100.00 12 0 -100.00
2017-11-09 13F-HR TFS CAPITAL LLC 17,419 0 -100.00 18 0 -100.00
2018-04-09 13F-HR SHEETS SMITH WEALTH MANAGEMENT 12,635 0 -100.00 12 0 -100.00
2018-05-15 13F-HR TWO SIGMA INVESTMENTS LLC 23,820 0 -100.00 23 0 -100.00
2018-05-15 13F-HR STATE STREET CORP 24,767 0 -100.00 22 0 -100.00
2018-05-15 13F-HR BANK OF AMERICA CORP /DE/ 16,390 1,711 -89.56 16 16 0.00
2018-05-14 13F-HR Virtu Financial LLC 60,347 0 -100.00 57 0 -100.00
2018-05-15 13F-HR BRIDGEWAY CAPITAL MANAGEMENT INC 248,000 24,800 -90.00 235 229 -2.55
2018-05-15 13F-HR GEODE CAPITAL MANAGEMENT, LLC 253,385 25,337 -90.00 240 233 -2.92
2017-01-13 13F-HR MetLife Securities, Inc 1,230 0 -100.00 2 0 -100.00
2018-05-14 13F-HR SMITH, MOORE & CO. 100,000 10,000 -90.00 95 92 -3.16
2018-05-01 13F-HR PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO 19,167 1,916 -90.00 18 18 0.00
2018-05-15 13F-HR GUGGENHEIM CAPITAL LLC 14,317 0 -100.00 14 0 -100.00
2018-04-20 13F-HR FIRST MANHATTAN CO 288 0 -100.00 0 0
2018-05-15 13F-HR Cubist Systematic Strategies, LLC 74,903 0 -100.00 71 0 -100.00
2018-05-09 13F-HR FEDERATED INVESTORS INC /PA/ 6,908 0 -100.00 7 0 -100.00
2018-05-15 13F-HR UBS Group AG 24,395 692 -97.16 23 6 -73.91
2018-05-16 13F-HR Foundry Partners, LLC 536,625 0 -100.00 509 0 -100.00
2018-05-10 13F-HR Spark Investment Management LLC 44,085 0 -100.00 41 0 -100.00
2018-05-10 13F-HR JP Morgan Chase & Co 6,844 0 -100.00 6 0 -100.00
2018-05-15 13F-HR Tower Research Capital LLC (TRC) 0 1,090 0 10
2018-05-14 13F-HR FMR LLC / Fidelity 886,882 88,688 -90.00 841 818 -2.73
2018-05-15 13F-HR BARCLAYS PLC 54 33 -38.89 0 0
2018-05-15 13F-HR SUSQUEHANNA INTERNATIONAL GROUP, LLP 17,622 0 -100.00 17 0 -100.00
2018-05-14 13F-HR Renaissance Technologies LLC 1,751,212 185,240 -89.42 1,661 1,696 2.11
2018-05-09 13F-HR BlackRock Inc. 169,479 1,552
2018-05-10 13F-HR CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 120,300 0 -100.00 114 0 -100.00

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...

Related News Stories

Zacks.com featured highlights include: Weight Watchers, Johnson Outdoors, ChemoCentryx, Harte-Hanks and IEC

2018-07-02 zacks
Chicago, IL – June 29, 2018 - Stocks in this week’s article Weight Watchers International, Inc. (WTW - Free Report) , Johnson Outdoors Inc. (JOUT - Free Report) , ChemoCentryx, Inc. (CCXI - Free Report) , Harte-Hanks, Inc. (HHS - Free Report) and IEC Electronics Corp. (IEC - Free Report) . (47-0)

7 Stocks With Recent Price Strength to Enhance Your Returns

2018-06-29 zacks
“In the stock game, winning means reaching a higher price.” However, striking the right chord each time needs a fair amount of luck. No matter how disciplined and systematic investors are, equity market volatility will always manage to get the better of them. While a few lucky ones rake in the moolah, others fall victim to ad hoc strategies. One could resort to commonly used techniques to find beaten down stocks that have the potential to recover faster than others. (20-1)

Why MDC Partners (MDCA) Could Be Positioned for a Slump

2018-05-23 zacks
Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to get rid of the security before more losses hit your portfolio. One such stock that you may want to consider dropping is MDC Partners Inc. (MDCA - Free Report) , which has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year. (9-0)

Hortonworks, Inc. (HDP) Sees Hammer Chart Pattern: Time to Buy?

2018-05-16 zacks
Hortonworks, Inc. (HDP - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because HDP recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom. (19-1)

Adecoagro S.A. (AGRO) Sees Hammer Chart Pattern: Time to Buy?

2018-05-16 zacks
Adecoagro S.A. (AGRO - Free Report) has been struggling lately, but the selling pressure may be coming to an end soon. That is because AGRO recently saw a Hammer Chart Pattern which can signal that the stock is nearing a bottom. (18-0)

CUSIP: 416196103